• David Rodeberg
  • Eugene S. Wiener


Clin Oncol Second Look Operation Childhood Cancer Survivor Study Primary Excision Intergroup Rhabdomyosarcoma Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gurney JG, Wall DA, Jukich PJ, Davis FG. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 1999;10(2):101–105.PubMedCrossRefGoogle Scholar
  2. 2.
    Raney RB Jr, Tefft M, Maurer HM, et al. Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I. Cancer 1988;62(7):1257–1266.PubMedCrossRefGoogle Scholar
  3. 3.
    Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13(3):610–630.PubMedGoogle Scholar
  4. 4.
    Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341(5):342–352.PubMedCrossRefGoogle Scholar
  5. 5.
    Newton WA Jr, Meadows AT, Shimada H, Bunin GR, Vawter GF. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer 1991;67(1):193–201.PubMedCrossRefGoogle Scholar
  6. 6.
    Rodeberg D. Surgical principles for children/adolescents with newly diagnosed rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Sarcoma 2002;6(4):111–122.CrossRefGoogle Scholar
  7. 7.
    Tabrizi P, Letts M. Childhood rhabdomyosarcoma of the trunk and extremities. Am J Orthop 1999;28(8):440–446.PubMedGoogle Scholar
  8. 8.
    Hays DM, Lawrence W, Wharam M, et al. Primary reexcision for patients with ‘microscopic residual’ tumor following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 1989;24(1): 5–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Hays DM, Raney RB, Crist WM, et al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 1990;25(10):1100–1105.PubMedCrossRefGoogle Scholar
  10. 10.
    Andrassy RJ. Rhabdomyosarcoma. Semin Pediatr Surg 1997;6(1):17–23.PubMedGoogle Scholar
  11. 11.
    Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2000;18(12):2427–2434.PubMedGoogle Scholar
  12. 12.
    Shields JA, Shields CL. Rhabdomyosarcoma of the orbit. Int Ophthalmol Clin 1993;33(3):203–210.PubMedCrossRefGoogle Scholar
  13. 13.
    Andrassy RJ, Wiener ES, Raney RB, et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 1999;34(5):731–734; discussion 734–735.PubMedCrossRefGoogle Scholar
  14. 14.
    Spunt SL, Lobe TE, Pappo AS, et al., Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 2000;35(2):309–316.PubMedCrossRefGoogle Scholar
  15. 15.
    Heyn R, Newton WA, Raney RB, et al. Preservation of the bladder in patients with rhabdomyosarcoma. J Clin Oncol 1997;15(1):69–75.PubMedGoogle Scholar
  16. 16.
    Arndt C, Rodeberg D, Breitfeld PP, Raney RB, Ullrich F, Donaldson S. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study IV. J Urol 2004;171(6 Pt 1):2396–2403.PubMedCrossRefGoogle Scholar
  17. 17.
    Arndt CA, Donaldson SS, Anderson JR, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 2001;91(12):2454–2468.PubMedCrossRefGoogle Scholar
  18. 18.
    Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg 2000;35(2):317–321.PubMedCrossRefGoogle Scholar
  19. 19.
    Lawrence W Jr, Hays DM, Heyn R, et al. Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 1987;60(4):910–915.PubMedCrossRefGoogle Scholar
  20. 20.
    Wiener ES, Anderson JR, Ojimba JI, et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 2001;10(3):146–152.PubMedCrossRefGoogle Scholar
  21. 21.
    Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg 2000;35(6):961–964.PubMedCrossRefGoogle Scholar
  22. 22.
    Cecchetto G, Guglielmi M, Inserra A, et al. Primary re-excision: the Italian experience in patients with localized soft-tissue sarcomas. Pediatr Surg Int 2001;17(7):532–534.PubMedCrossRefGoogle Scholar
  23. 23.
    Ortega JA, Wharam M, Gehan EA, et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1991;9(5):796–801.PubMedGoogle Scholar
  24. 24.
    Wiener E. Pediatric Rhabdomysarcoma. In: Postgraduate general surgery, volume three. Austin: R.G. Landes Company; 1991.Google Scholar
  25. 25.
    Hawkins D, Stoner J, Kao S, Rodeberg D, Hayes-Jordan A, Qualman S, Wolden S, Meyer W. Children's Oncology Group. Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS) IV experience. Abstract Presented at American Society of Clinical Oncology; 2005.Google Scholar
  26. 26.
    David A Rodeberg, Andrea Hayes-Jordan, Julie Stoner, Chuck Paidas, Ken Brown, Lor Randall, Eugene Wiener, Doug Hawkins. Soft Tissue Sarcoma Committee, Children's Oncology Group. Resection of Residual Masses at the End of Therapy for Rhabdomyosarcoma (RMS). Abstract Presented at American Pediatric Surgical Association; 2006.Google Scholar
  27. 27.
    Raney RB Jr, Crist WM, Maurer HM, Foulkes MA. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the Intergroup Rhabdomyosarcoma Study I. Cancer 1983;52(1):44–50.PubMedCrossRefGoogle Scholar
  28. 28.
    Klingebiel T, Pertl U, Hess CF, et al. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol 1998;30(5):269–275.PubMedCrossRefGoogle Scholar
  29. 29.
    Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999;17(11):3487–3493.PubMedGoogle Scholar
  30. 30.
    Hayes-Jordan A, Doherty DK, West SD, et al. Outcome after surgical resection of recurrent rhabdomyosarcoma. J Pediatr Surg 2006;41(4):633–638; discussion 633–638.PubMedCrossRefGoogle Scholar
  31. 31.
    Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 1988;61(2):209–220.PubMedCrossRefGoogle Scholar
  32. 32.
    Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71(5):1904–1922.PubMedCrossRefGoogle Scholar
  33. 33.
    Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003;21(1):78–84.PubMedCrossRefGoogle Scholar
  34. 34.
    Rodeberg D, Arndt C, Breneman J, et al. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. J Pediatr Surg 2005;40(1):256–262; discussion 262.PubMedCrossRefGoogle Scholar
  35. 35.
    Temeck BK, Wexler LH, Steinberg SM, McClure LL, Horowitz M, Pass HI. Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg 1995;59(6): 1385–1389; discussion 1390.PubMedCrossRefGoogle Scholar
  36. 36.
    Williams BA, Williams KM, Doyle J, et al. Metastatic rhabdomyosarcoma: a retrospective review of patients treated at the hospital for sick children between 1989 and 1999. J Pediatr Hematol Oncol 2004;26(4):243–247.PubMedCrossRefGoogle Scholar
  37. 37.
    Koscielniak E, Rodary C, Flamant F, et al. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 1992;20(3):209–214.PubMedCrossRefGoogle Scholar
  38. 38.
    Carli M, Colombatti R, Oberlin O, et al. European intergroup studies (MMT4–89 and MMT4–91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 2004;22(23):4787–4794.PubMedCrossRefGoogle Scholar
  39. 39.
    Sandler E, Lyden E, Ruymann F, et al. Efficacy of ifosfamide and doxorubicin given as a phase II “window” in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Med Pediatr Oncol 2001;37(5):442–448.PubMedCrossRefGoogle Scholar
  40. 40.
    Walterhouse DO, Lyden ER, Breitfeld PP, Qualman SJ, Wharam MD, Meyer WH. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. J Clin Oncol 2004;22(8): 1398–1403.PubMedCrossRefGoogle Scholar
  41. 41.
    Weigel BJ, Breitfeld PP, Hawkins D, Crist WM, Baker KS. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 2001;23(5):272–276.PubMedCrossRefGoogle Scholar
  42. 42.
    Wolden SL, Anderson JR, Crist WM, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 1999;17(11):3468–3475.PubMedGoogle Scholar
  43. 43.
    Punyko JA, Mertens AC, Gurney JG, et al. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2005;44(7):643–653.PubMedCrossRefGoogle Scholar
  44. 44.
    Raney RB, Asmar L, Vassilopoulou-Sellin R, et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999;33(4):362–371.PubMedCrossRefGoogle Scholar
  45. 45.
    Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 2005;23(28):7143–7151.PubMedCrossRefGoogle Scholar
  46. 46.
    Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005;103(11):2391–2396.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press 2008

Authors and Affiliations

  • David Rodeberg
  • Eugene S. Wiener

There are no affiliations available

Personalised recommendations